Literature DB >> 10701362

Fatigue patterns observed in patients receiving chemotherapy and radiotherapy.

A L Schwartz1, L M Nail, S Chen, P Meek, A M Barsevick, M E King, L S Jones.   

Abstract

The purpose of this study was to describe the patterns of cancer-related fatigue (CRF) and vigor in patients receiving chemotherapy or radiation therapy. Five studies that measured fatigue and vigor with the Profile of Mood States were used to describe the pattern of CRF and vigor during and after both types of treatment. Repeated-measures ANOVA was used to determine differences over time in each study. Results demonstrate different patterns of CRF for patients receiving chemotherapy and radiation therapy. Chemotherapy-related CRF peaks in the days after chemotherapy, whereas radiation therapy-related CRF gradually accumulates over the course of treatment. The CRF associated with both forms of treatment gradually declines over time. The prevalence, intensity, and persistence of CRF during treatment and for months after treatment is complete make this symptom one that cannot be ignored.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10701362     DOI: 10.3109/07357900009023057

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  30 in total

1.  Fatigue patterns and correlates in male liver cancer patients receiving transcatheter hepatic arterial chemoembolization.

Authors:  Shiow-Ching Shun; Yeur-Hur Lai; Ting-Ting Jing; Chii Jeng; Fa-Yau Lee; Li-Shia Hu; Sue-Yueh Cheng
Journal:  Support Care Cancer       Date:  2004-12-21       Impact factor: 3.603

2.  Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer.

Authors:  Cielito C Reyes-Gibby; Lu Ann Aday; Karen O Anderson; Tito R Mendoza; Charles S Cleeland
Journal:  J Pain Symptom Manage       Date:  2006-08       Impact factor: 3.612

3.  Validation of the Hindi version of the Multidimensional Fatigue Inventory-20 (MFI-20) in Indian cancer patients.

Authors:  Priyanka Chandel; Armiya Sultan; Khan Abraruzzaman Khan; Vivek Choudhary; Arti Parganiha
Journal:  Support Care Cancer       Date:  2015-03-06       Impact factor: 3.603

4.  Occurrence and predictors of the fatigue in high-grade glioma patients.

Authors:  Irene Aprile; Silvia Chiesa; Luca Padua; Chiara Di Blasi; Maria Felice Arezzo; Vincenzo Valentini; Enrico Di Stasio; Mario Balducci
Journal:  Neurol Sci       Date:  2015-02-20       Impact factor: 3.307

Review 5.  Management of fatigue in cancer patients.

Authors:  Mellar P Davis; Dilara Khoshknabi; Guang H Yue
Journal:  Curr Pain Headache Rep       Date:  2006-08

6.  Accelerated partial breast irradiation compared with whole breast radiation therapy: a breast cancer cohort study measuring change in radiation side-effects severity and quality of life.

Authors:  M Pérez; M Schootman; L E Hall; D B Jeffe
Journal:  Breast Cancer Res Treat       Date:  2017-01-28       Impact factor: 4.872

7.  Taltirelin alleviates fatigue-like behavior in mouse models of cancer-related fatigue.

Authors:  John P Dougherty; Brian S Wolff; Mary J Cullen; Leorey N Saligan; Marvin C Gershengorn
Journal:  Pharmacol Res       Date:  2017-07-15       Impact factor: 7.658

8.  A role for orexin in cytotoxic chemotherapy-induced fatigue.

Authors:  K B Weymann; L J Wood; X Zhu; D L Marks
Journal:  Brain Behav Immun       Date:  2013-11-09       Impact factor: 7.217

9.  Comparison of groups with different patterns of symptom cluster intensity across the breast cancer treatment trajectory.

Authors:  Hee-Ju Kim; Paul A McDermott; Andrea M Barsevick
Journal:  Cancer Nurs       Date:  2014 Mar-Apr       Impact factor: 2.592

10.  Relationship between fatigue, sleep quality and inflammatory cytokines during external beam radiation therapy for prostate cancer: A prospective study.

Authors:  Emma B Holliday; Nathan F Dieckmann; Tasha L McDonald; Arthur Y Hung; Charles R Thomas; Lisa J Wood
Journal:  Radiother Oncol       Date:  2015-12-29       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.